ASCVD Risk Calculator
An interactive implementation of the 2013 ACC/AHA Pooled Cohort Equations (Goff et al.): estimates the 10-year risk of a first hard atherosclerotic cardiovascular event for adults aged 40 to 79 without known cardiovascular disease.
Enter age, sex, race, total and HDL cholesterol, systolic blood pressure, blood pressure treatment status, smoking status and diabetes status to estimate 10-year ASCVD risk with the Pooled Cohort Equations. Use the result to guide the clinician-patient discussion about statin therapy and other preventive measures, following the 2018 AHA/ACC cholesterol guideline risk bands.
What is the ASCVD risk calculator?
The ASCVD risk calculator implements the Pooled Cohort Equations, the risk model at the centre of modern cardiovascular prevention guidelines. Published by Goff and co-workers in 2013 alongside the American College of Cardiology and American Heart Association guideline on the assessment of cardiovascular risk, the equations were derived from pooled data of several landmark US cohort studies, including the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, the Coronary Artery Risk Development in Young Adults study and the Framingham Offspring Study. Together these cohorts contributed tens of thousands of participants followed for a decade or more, which is why the model is called pooled cohort.
The purpose of the tool is practical: to move the decision about preventive therapy, especially statins, away from single risk factors and toward absolute risk. Two patients can have the same cholesterol level yet very different 10-year event probabilities once age, blood pressure, smoking and diabetes are taken into account. Guidelines since 2013 have anchored statin recommendations to these absolute risk bands, and the 2018 AHA/ACC cholesterol guideline kept the Pooled Cohort Equations as the starting point for the clinician-patient risk discussion. The same tool is searched for under several names: cardiovascular risk calculator, cardiac risk calculator and heart risk calculator all describe an estimator of this kind, and ASCVD simply names the disease process, atherosclerotic cardiovascular disease, whose risk it calculates.
Who the calculator applies to
The equations were derived and validated in adults aged 40 to 79 years who were free of cardiovascular disease at baseline. They are intended for primary prevention, which means estimating the risk of a first event in someone without established ASCVD. They should not be applied to people who have already had a heart attack, a stroke, a coronary stent or bypass surgery, or a diagnosis of peripheral artery disease, because secondary prevention follows different rules and the absolute risk in those patients is already high.
Age limits matter. Below 40, the equations are not validated, and the guideline instead recommends estimating lifetime risk to motivate early lifestyle change. Above 79, competing risks and the lack of derivation data make the estimates unreliable, and decisions lean more heavily on overall health, frailty and patient preference. Within the 40 to 79 window the calculator accepts the values the cohorts actually observed; extreme inputs outside those ranges are rejected by the input checks.
The variables and why each one counts
Age is the strongest driver of absolute risk in every equation, which is why an older person with otherwise modest risk factors can still land in a high risk band. Sex and race select which of the four published equations is used, because the relationship between risk factors and events differs across these groups in the derivation data. Total cholesterol and HDL cholesterol capture the lipid contribution in opposite directions: higher total cholesterol raises predicted risk while higher HDL cholesterol lowers it. Systolic blood pressure enters the model, and the equations distinguish treated from untreated values, because someone whose pressure is 130 mm Hg on medication carries more underlying risk than someone at 130 mm Hg without treatment.
Smoking and diabetes are the two binary clinical variables, and both carry substantial weight. In the White male equation, for example, current smoking contributes roughly as much to the linear predictor as a large cholesterol difference. Diabetes not only raises the calculated risk but also triggers separate guideline recommendations: adults with diabetes aged 40 to 75 are generally advised to take at least a moderate-intensity statin whatever the calculated number, so the calculator result complements rather than replaces that rule.
How to interpret the result
The 2018 AHA/ACC cholesterol guideline groups 10-year ASCVD risk into four bands. Under 5 percent is low risk, where lifestyle optimisation is the mainstay and statins are generally not indicated. From 5 to under 7.5 percent is borderline risk, where the decision benefits from a clinician-patient discussion and sometimes additional testing. From 7.5 to under 20 percent is intermediate risk, the zone where most risk discussions happen: a moderate- to high-intensity statin is favoured when risk-enhancing factors are present, and a coronary artery calcium score can reclassify the patient up or down. At 20 percent or above, risk is high and a high-intensity statin is generally recommended to lower LDL cholesterol by at least half.
Risk-enhancing factors deserve emphasis because they are the guideline's mechanism for personalising a population equation. Family history of premature ASCVD, persistently elevated triglycerides, chronic inflammatory conditions such as rheumatoid arthritis or psoriasis, premature menopause, South Asian ancestry and several biomarkers can all shift the decision toward treatment when the calculated risk sits near a threshold. When uncertainty remains after considering these factors, a coronary artery calcium score is the preferred tiebreaker: a score of zero can defer statin therapy in many intermediate-risk patients, while scores above 100 or above the 75th percentile for age and sex argue for treatment.
Limitations
The Pooled Cohort Equations have well-documented limitations. They were derived in US White and African American cohorts, so their calibration in other populations is imperfect; the guideline advises using the White equations for other groups while recognising the potential for over- or underestimation. The equations tend to overestimate risk in contemporary, lower-risk populations, partly because event rates have fallen since the cohorts were assembled. They do not incorporate family history, coronary calcium, lipoprotein(a), or socioeconomic context, all of which modify real-world risk. Finally, the output is a probability, not a prediction for the individual: a 10 percent risk means 90 out of 100 similar people will not have an event in 10 years, and the number should inform, not dictate, shared decision making.
References
- Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49-S73.
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082-e1143.
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;140(11):e596-e646.
Key takeaways
- The Pooled Cohort Equations estimate 10-year risk of a first hard ASCVD event (heart attack, coronary death or stroke) in adults aged 40 to 79 without known cardiovascular disease.
- Risk bands from the 2018 cholesterol guideline are under 5 percent (low), 5 to under 7.5 percent (borderline), 7.5 to under 20 percent (intermediate) and 20 percent or higher (high).
- High risk generally warrants a high-intensity statin; intermediate risk calls for a clinician-patient discussion weighing risk-enhancing factors, with coronary artery calcium scoring as the preferred tiebreaker.
- Adults with diabetes aged 40 to 75 and anyone with LDL cholesterol of 190 mg/dL or higher have statin indications that do not depend on the calculated risk.
- The equations were derived in White and African American US cohorts; for other groups use the White equations cautiously and lean on risk-enhancing factors and clinical judgment.
Frequently asked questions
What does the ASCVD risk calculator estimate?
It estimates the 10-year probability of a first hard atherosclerotic cardiovascular event, defined as nonfatal myocardial infarction, coronary heart disease death, or fatal or nonfatal stroke, for adults aged 40 to 79 who do not already have cardiovascular disease. It implements the Pooled Cohort Equations published by Goff and colleagues in 2013 as part of the ACC/AHA cardiovascular risk assessment guideline.
Who should not use the Pooled Cohort Equations?
The equations should not be used in people younger than 40 or older than 79, in anyone with established atherosclerotic cardiovascular disease such as a prior heart attack, stroke or revascularization, or as a substitute for clinical judgment when risk factor values fall far outside the derivation cohorts. They are designed for primary prevention decision making.
What do the ASCVD risk categories mean?
The 2018 AHA/ACC cholesterol guideline groups 10-year risk as low (under 5 percent), borderline (5 to under 7.5 percent), intermediate (7.5 to under 20 percent) and high (20 percent or higher). High risk generally warrants a high-intensity statin, intermediate risk calls for a risk discussion weighing risk-enhancing factors, and borderline risk may prompt additional testing such as a coronary artery calcium score.
Which race should I select if the patient is neither White nor African American?
The equations were derived in White and African American cohorts, so the guideline recommends using the White equations for other groups, recognising that this may overestimate risk in some populations such as East Asian Americans and underestimate it in others such as South Asian Americans. Risk-enhancing factors and clinical judgment should refine the estimate.
Does a low 10-year risk mean no treatment is needed?
Not necessarily. Ten-year risk can be low in younger adults who still carry high lifetime risk, and the guideline advises considering lifetime risk, risk-enhancing factors such as family history of premature disease or chronic inflammatory conditions, and coronary artery calcium scoring when the treatment decision is uncertain. People with diabetes aged 40 to 75, or with LDL cholesterol of 190 mg/dL or higher, have separate statin indications regardless of the calculated risk.
Should treated and untreated blood pressure be entered differently?
Yes. The equations use separate coefficients for treated and untreated systolic blood pressure, because the same pressure value carries different meaning depending on whether medication was needed to achieve it. Always answer the treatment question according to whether the patient takes blood pressure lowering medication.
What is a cardiovascular risk calculator?
A cardiovascular risk calculator estimates the probability that a person will suffer a cardiovascular event, such as a heart attack or stroke, over a defined period, usually the next 10 years. This page is one: it applies the ASCVD Pooled Cohort Equations to age, sex, race, cholesterol, blood pressure, smoking and diabetes to produce a 10-year risk percentage, which guidelines then use to guide preventive treatment such as statin therapy.
Is a cardiac risk calculator the same as an ASCVD calculator?
Essentially yes. Cardiac risk calculator, heart risk calculator and ASCVD risk calculator are different names for tools that estimate the risk of heart and blood vessel events. ASCVD stands for atherosclerotic cardiovascular disease. The calculator on this page specifically implements the 2013 ACC/AHA Pooled Cohort Equations; other cardiac risk calculators may use different models, such as SCORE2 or QRISK, so the same person can receive somewhat different estimates from different tools.